Allogene Therapeutics (ALLO) P/BV US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/BV | ? | 4.18 | 2.81 | 2.21 | 1.35 | 0.98 | 1.34 | ||
| Changes by years, y/y, % | +276% | -33% | -21% | -39% | -27% | -2.4% | |||
Allogene Therapeutics. P/BV
Allogene Therapeutics. P/BV, changes, %
Allogene Therapeutics (ALLO) P/BV US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/BV | ? | 0.91 | 1.05 | 1.64 | 0.86 | 1.26 | 1.34 | |
| Changes by years, y/y, % | -57% | -23% | +36% | -27% | +39% | |||
| Changes by quarters, q/q, % | -22% | +16% | +55% | -48% | +47% | |||